09-07-2007 Comments (0)
ActonelActosAlphaAvandiaBenicarBenicar HCTDaiichi SankyoEisaiFlecainideGlaxoSmithKlineGSKHumulin 70-30Humulin NHumulin RInsulinolmesartanOlmesartan Medoxomil-HydrochlorothiazidePioglitazoneProlastinRisedronate SodiumRocherosiglitazoneSankyoTambocor
Tokyo rebounded moderately in the week ended July 2. The Nikkei 225 edged up 0.3%, to close at the...
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.